- Home
- ATYR vs CRNT Comparison
ATYR vs CRNT Comparison
Compare ATYR & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | CRNT |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 189.7M |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ATYR | CRNT |
|---|---|---|
| Price | $0.81 | $2.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $8.75 | $4.00 |
| AVG Volume (30 Days) | ★ 2.0M | 534.4K |
| Earning Date | 11-06-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $190,000.00 | ★ $363,330,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18,728.88 | $5.06 |
| P/E Ratio | ★ N/A | $132.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $1.82 |
| 52 Week High | $7.29 | $5.73 |
Technical Indicators
Market Signals| Indicator | ATYR | CRNT |
|---|---|---|
| Relative Strength Index (RSI) | 55.62 | 50.78 |
| Support Level | $0.70 | $2.05 |
| Resistance Level | $0.75 | $2.15 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 76.89 | 76.15 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.